OptiLight by Lumenis
https://treatmydryeye.com/wp-content/uploads/2023/01/blog.jpg

Medical Journal

Eyedrops for dry eyes – one solution fit all?

Eye drops for dry eyes – are they a real solution?

Dry eye is an inflammatory disease that may be caused by injury, infection, or irritation. It may be a result of aging, certain medications, a medical condition, eye surgery, or environmental factors, such…

Read more
20
rosacea

What is ocular rosacea?

Many people are familiar with facial rosacea, a chronic skin condition that occurs on the face. Ocular rosacea is a similar inflammatory…

Read more
18

Eyedrops for dry eyes – one solution fit all?

Eye drops for dry eyes – are they a real solution?

Dry eye is…

Read more
6
קטק

Irritated, dry eyelids? Help is at hand

The skin around your eyes is very delicate, this means that it is very prone to…

Read more
I'm a doctor
Find a doctor near me
OptiLight Logo
Instagram Facebook Linkedin Youtube
*This testimonial describes a specific experience of a paid spokesperson. The experience of other people may vary
Indications for Use:

Improvement of signs of Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye, in patients 22 years of age and older with moderate to severe signs and symptoms of DED due to MGD and with Fitzpatrick skin types I-IV. IPL is to be applied only to skin on the malar region of the face, from tragus to tragus including the nose (eyes should be fully covered by protective eyewear). IPL is intended to be applied as an adjunct to other modalities, such as meibomian gland expression, artificial tear lubricants and warm compresses

Treatment with OptiLight is contraindicated for patients with the following conditions in the treatment area:

Ocular surgery or eyelid surgery or Neuro-paralysis within 6 months prior to the first treatment; Uncontrolled eye disorders affecting the ocular surface; Pre-cancerous lesions, skin cancer or pigmented lesions in the planned treatment area; Uncontrolled infections or uncontrolled immunosuppressive diseases; Recent Ocular infections; Prior history of cold sores or rashes in the perioral area, including: Herpes simplex 1 & 2, Systemic Lupus erythematosus and porphyria; Use of photosensitive medication and/or herbs that may cause sensitivity within 3 months prior to the first IPL session; Recent radiation therapy to the head or neck or planned radiation therapy; Recent treatment with a chemotherapeutic agent or planned chemotherapy; History of migraines, seizures or epilepsy.
The patients' eyes must be completely occluded during the treatment. Please refer to the operator manual for a complete list of intended use, contraindications, and risks.
Please consult your physician as to whether this procedure is suitable for you.

The following possible side effects can occur following IPL treatments:

Pain/discomfort, damage to natural skin texture, change of pigmentation, scarring, excessive edema, fragile skin, bruising, burns, pruritus and xerosis. Please refer to the user manual or ask your doctor for a complete list of intended uses, contraindications, and risks

OptiLight is intended to be used by licensed practitioners, according to local rules and regulations

Sources

1 USA General Population 2018 Cross Sectional Study and Census.gov Population Clock
2 Kheirkhah et al., Patients' Preceived Treatment Effectiveness in Dry Eye Disease, The Journal of Cornea and External Disease, 2017
3 https://theophthalmologist.com/subspecialties/the-burden-of-dry-eye-disease


PB-00039850 Rev B

Copyright © 2023 Lumenis Be Ltd. All Rights Reserved
Privacy policy | Terms of use